Anzeige
Mehr »
Mittwoch, 29.04.2026 - Börsentäglich über 12.000 News
Zuerst +50%… jetzt ein $20M Graphen-Deal
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Stockhead

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
05:50Lunch Wrap: ASX trims losses as CPI comes in at 4.6pc
05:50Health Check: Syntara goes to the well for $10 million to fund advanced cancer trial
05:50Budget CGT plan threatens to hit younger sharemarket investors
DiRise and Shine: Everything you need to know before the ASX opens
DiBiocurious: Why biotech's big end of town has lost its mojo
DiCultivating unicorns: Strategic Elements incubates Australian tech breakthrough
DiClosing Bell: Energy stands alone as ASX extends losing streak
DiResources Top 5: Another Richardson Street Group special wins the day for Oceana
DiKey strategies to boost your retirement wealth in your 60s
DiHealth Check: At quarter time, who is taking 'speccies' and who is headed for the bench?
DiLunch Wrap: Origin Energy's Octopus hit drags ASX lower
MoExplorers Podcast: Litchfield advances NT polymetallic hunt with BHP backing
MoASX explorers flock to the Balkans as Tethyan Belt boom builds steam
MoDr Boreham's Crucible: Friendlier markets lead the way for Firebrick's respiratory virus killer
MoAgnico Eagle's $4bn Finnish cash splash puts focus on Nordic gold stocks
MoBrokers see upside in Dimerix as phase III kidney disease drug trial progresses
MoLong Shortz with Australian Oil Company: $2 million raise to drive Surat Basin growth
MoClosing Bell: Goldies and lithium stocks resist, but ASX cops another loss
MoResources Top 5: Precious metals see Patriot and Altair on winning runs
Mo'Supercomputing' blitz: Microsoft to spend $25bn on Aussie AI
MoLunch Wrap: ASX struggles to lift despite rising Chinese lithium futures
MoHealth Check: Paradigm holders go for extra fries in super-sized placement
MoTop 10 at 11: Chimeric has complete response in 60pc of leukemia cohort; market slides on open
MoWhy underspending is the new retirement 'regret risk'
SoTariff tensions are back on the menu but markets aren't biting